We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CSPHF market cap is 289.59M. The company's latest EPS is CNY -0.2860 and P/E is -0.80.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 0 | 1.04B | 243.72M | 481.36M | 463.84M |
| Operating Income | -1.74B | -1.06B | -1.79B | -903.1M | -579.85M |
| Net Income | -2.31B | -1.22B | -1.92B | -902.68M | -367.23M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 2.95B | 3.76B | 2.27B | 1.64B | 1.66B |
| Total Liabilities | 469.06M | 808.29M | 1.06B | 1.19B | 1.21B |
| Total Equity | 2.48B | 2.95B | 1.21B | 449.33M | 456.83M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -1.08B | -508.07M | -1.48B | -612.47M | -588.84M |
| Investing | -658.88M | 1.18B | -826.55M | 365.12M | 619.61M |
| Financing | 2.09B | 1.39B | 92.3M | 28.47M | 388.36M |
| Market Cap | 289.59M |
| Price to Earnings Ratio | -0.80 |
| Price to Sales Ratio | 0.64 |
| Price to Cash Ratio | 0.3 |
| Price to Book Ratio | 0.65 |
| Dividend Yield | - |
| Shares Outstanding | 1.28B |
| Average Volume (1 week) | 50.1k |
| Average Volume (1 Month) | 485.55k |
| 52 Week Change | -14.19% |
| 52 Week High | 0.33 |
| 52 Week Low | 0.1139 |
| Spread (Intraday) | 0.13 (40.69%) |
| Company Name | CStone Pharmaceuticals (PK) |
| Address |
the offices of vistra (cayman) limited grand cayman KY1-1205 |
| Website | https://www.cstonepharma.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
